Biofrontera Inc.
Clinical trials sponsored by Biofrontera Inc., explained in plain language.
-
New light therapy could zap precancerous skin spots on Hard-to-Treat areas
Disease control OngoingThis study tests a gel (Ameluz®) plus red light therapy for actinic keratosis, rough precancerous patches on skin. It includes 172 adults with 4-15 spots on arms, legs, neck, or trunk. The goal is to see if the treatment clears these spots better than a placebo gel.
Phase: PHASE3 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New light therapy could zap skin cancer without surgery
Disease control OngoingThis Phase 3 trial tests whether a gel called Ameluz® combined with a special red light can effectively treat superficial basal cell carcinoma, a common skin cancer. About 187 adults with at least one lesion are enrolled. The main goal is to see if the treated skin cancer clears …
Phase: PHASE3 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New light therapy could zap stubborn acne without pills
Disease control OngoingThis study tests a treatment called photodynamic therapy (PDT) for adults with moderate to severe acne. A gel called Ameluz® is applied to the face, then activated with a special red light. The goal is to see if this combination reduces acne lesions better than a placebo. About 1…
Phase: PHASE2 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC